Cargando…

Association Between Inflammatory Cytokines, Executive Function, and Substance Use in Patients With Opioid Use Disorder and Amphetamine-Type Stimulants Use Disorder

BACKGROUND: Long-term opioid and amphetamine-type stimulants (ATS) abuse may affect immunological function and impair executive function. We aimed to determine whether biomarkers of inflammation and executive function were associated with substance use in individuals with opioid use disorder (OUD) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tzu-Yun, Lu, Ru-Band, Lee, Sheng-Yu, Chang, Yun-Hsuan, Chen, Shiou-Lan, Tsai, Tsung-Yu, Tseng, Huai-Hsuan, Chen, Po See, Chen, Kao Chin, Yang, Yen Kuang, Hong, Jau-Shyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850661/ https://www.ncbi.nlm.nih.gov/pubmed/36181736 http://dx.doi.org/10.1093/ijnp/pyac069

Ejemplares similares

ALDH2 Gene: Its Effects on the Neuropsychological Functions in Patients with Opioid Use Disorder Undergoing Methadone Maintenance Treatment
por: Lee, Po-Wei, et al.
Publicado: (2020)

Correlation between loneliness, personality traits, and treatment outcomes in patients with methamphetamine use disorder
por: Tsai, Tsung-Yu, et al.
Publicado: (2022)

Dextromethorphan Protect the Valproic Acid Induced Downregulation of Neutrophils in Patients with Bipolar Disorder
por: Lu, Ru-Band, et al.
Publicado: (2020)

Low-dose add-on memantine treatment may improve cognitive performance and self-reported health conditions in opioid-dependent patients undergoing methadone-maintenance-therapy
por: Chang, Yun-Hsuan, et al.
Publicado: (2015)

Memory Impairment and Plasma BDNF Correlates of the BDNF Val66Met Polymorphism in Patients With Bipolar II Disorder
por: Chang, Yun-Hsuan, et al.
Publicado: (2018)

Corrigendum: Low-dose add-on memantine treatment may improve cognitive performance and self-reported health conditions in opioid-dependent patients undergoing methadone-maintenance-therapy
por: Chang, Yun-Hsuan, et al.
Publicado: (2017)

Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial
por: Lee, Sheng-Yu, et al.
Publicado: (2020)

Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial
por: Lee, Sheng-Yu, et al.
Publicado: (2015)

Impairment in Emotional Intelligence May Be Mood-Dependent in Bipolar I and Bipolar II Disorders
por: Kuo, Shih-Yu, et al.
Publicado: (2021)

A Placebo-Controlled Trial of Dextromethorphan as an Adjunct in Opioid-Dependent Patients Undergoing Methadone Maintenance Treatment
por: Lee, Sheng-Yu, et al.
Publicado: (2015)

The aldehyde dehydrogenase 2 polymorphisms on neuropsychological performance in bipolar II disorder with or without comorbid anxiety disorder
por: Lu, Ru-Band, et al.
Publicado: (2018)

Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder
por: Wang, Tzu-Yun, et al.
Publicado: (2016)

The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese heroin-dependent patients
por: Chen, Shiou-Lan, et al.
Publicado: (2015)

Inflammation’s Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder
por: Lee, Sheng-Yu, et al.
Publicado: (2013)

Effects of mood episodes and comorbid anxiety on neuropsychological impairment in patients with bipolar spectrum disorder
por: Huang, Chih‐Chun, et al.
Publicado: (2020)

Loneliness and isolated living status in middle-aged and older adults in Taiwan: exploration on stress-related biomarkers, depressive symptoms, and disability
por: Tsai, Tsung-Yu, et al.
Publicado: (2022)

The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders
por: Wang, Tzu-Yun, et al.
Publicado: (2016)

A potential interaction between COMT and MTHFR genetic variants in Han Chinese patients with bipolar II disorder
por: Wang, Liang-Jen, et al.
Publicado: (2015)

The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder
por: Chang, Ting-Ting, et al.
Publicado: (2016)

Striatal Dopamine Transporter Availability is Associated with Sleep Disturbance among Patients with Bipolar I Disorder: A Single-photon Emission Computed Tomography Study Using [(99m)Tc] TRODAT-1
por: Lu, Tsung-Hua, et al.
Publicado: (2022)

The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review
por: Frost, Madeline C., et al.
Publicado: (2021)

The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism
por: Lee, Sheng-Yu, et al.
Publicado: (2016)

Associations of leptin and corticostriatal connectivity in bipolar disorder
por: Wei, Shyh-Yuh, et al.
Publicado: (2022)

Dysregulation of oxytocin and dopamine in the corticostriatal circuitry in bipolar II disorder
por: Wei, Shyh-Yuh, et al.
Publicado: (2020)

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk
por: Tardelli, Vitor, et al.
Publicado: (2023)

Does illicit amphetamine seizures quantity associated with amphetamine use disorder related admissions in Saudi Arabia?
por: Ramadan, Majed, et al.
Publicado: (2023)

The role of the GABA system in amphetamine-type stimulant use disorders
por: Jiao, Dongliang, et al.
Publicado: (2015)

Impulsive choice in individuals with comorbid amphetamine use disorder and attention deficit-hyperactivity disorder
por: Brynte, Christoffer, et al.
Publicado: (2023)

Association between amphetamine‐related disorders and dementia‐a nationwide cohort study in Taiwan
por: Tzeng, Nian‐Sheng, et al.
Publicado: (2020)

Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders
por: Harada, Takayuki, et al.
Publicado: (2019)

Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder
por: Alasmari, Fawaz, et al.
Publicado: (2022)

Poorer sustained attention in bipolar I than bipolar II disorder
por: Kung, Chian-Huei, et al.
Publicado: (2010)

S165. ALTERED ASSOCIATION BETWEEN PARIETAL GRAY-MATTER VOLUME AND DISSOCIATIVE SYMPTOMS IN SCHIZOPHRENIA: A VOXEL-BASED MORPHOMETRY STUDY
por: Tseng, Huai-Hsuan, et al.
Publicado: (2018)

FGF21 Is Associated with Metabolic Effects and Treatment Response in Depressed Bipolar II Disorder Patients Treated with Valproate
por: Chang, Hui Hua, et al.
Publicado: (2017)

Editorial: Opioids and opioid-use disorders
por: de Guglielmo, Giordano, et al.
Publicado: (2023)

Psychosocial Interventions for Amphetamine Type Stimulant Use Disorder: An Overview of Systematic Reviews
por: Tran, Mai Thi Ngoc, et al.
Publicado: (2021)

Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial
por: Xue, Xiaobin, et al.
Publicado: (2018)

The Interaction of Oxytocin and Social Support, Loneliness, and Cortisol Level in Major Depression
por: Tsai, Tsung-Yu, et al.
Publicado: (2019)

The Effectiveness of Topiramate in the Treatment of Amphetamine and Methamphetamine Use Disorder: A Randomized Controlled Trial
por: Moghaddam Sadegh, Amirali, et al.
Publicado: (2023)

Ambulatory detoxification in alcohol use disorder and opioid use disorder
por: Moore, Troy A.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_10nuojgmp9p6fvb9v7vmt2m4be